Search Query :
4TQH
Human transthyretin (ttr) complexed with 3-(9h-fluoren-9-ylideneaminooxy)ethanoic acid Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Stura, E.A.
Date: 2014-06-11 Method: X-RAY DIFFRACTION Resolution: 1.511 Å Organism(s): Homo Sapiens Sequences Data: 4TQH_A , 4TQH_B
4TQI
Human transthyretin (ttr) complexed with 3-(9h-fluoren-9-ylideneaminooxy)propanoic acid in a dual binding mode Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Stura, E.A.
Date: 2014-06-11 Method: X-RAY DIFFRACTION Resolution: 1.25 Å Organism(s): Homo Sapiens Sequences Data: 4TQI_A , 4TQI_B
4TQP
Human transthyretin (ttr) complexed with (r)-3-(9h-fluoren-9-ylideneaminooxy)-2-methyl-n-(methylsulfonyl) propionamide in a dual binding mode Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Stura, E.A.
Date: 2014-06-11 Method: X-RAY DIFFRACTION Resolution: 1.58 Å Organism(s): Homo Sapiens Sequences Data: 4TQP_A , 4TQP_B
4WZV
Crystal structure of a hydroxamate based inhibitor en140 in complex with the mmp-9 catalytic domain Deposition Author(s): Cassar-Lajeunesse, E. , Dive, V. , Nuti, E. , Rossello, A. , Stura, E.A. , Vera, L.
Date: 2014-11-20 Method: X-RAY DIFFRACTION Resolution: 1.65 Å Organism(s): Homo Sapiens Sequences Data: 4WZV_A , 4WZV_B
4XCT
Crystal structure of a hydroxamate based inhibitor arp101 (en73) in complex with the mmp-9 catalytic domain. Deposition Author(s): Cassar-Lajeunesse, E. , Dive, V. , Nuti, E. , Rossello, A. , Stura, E.A. , Tepshi, L. , Vera, L.
Date: 2014-12-18 Method: X-RAY DIFFRACTION Resolution: 1.3 Å Organism(s): Homo Sapiens Sequences Data: 4XCT_A
5CUH
Crystal structure mmp-9 complexes with a constrained hydroxamate based inhibitor lt4 Deposition Author(s): Nuti, E. , Rosalia, L. , Rossello, A. , Stura, E.A. , Tepshi, L. , Vera, L.
Date: 2015-07-24 Method: X-RAY DIFFRACTION Resolution: 1.83 Å Organism(s): Homo Sapiens Sequences Data: 5CUH_A , 5CUH_B
5E23
Human transthyretin (ttr) complexed with (2,7-dibromo-fluoren-9-ylideneaminooxy)-acetic acid Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Stura, E.A.
Date: 2015-09-30 Method: X-RAY DIFFRACTION Resolution: 1.41 Å Organism(s): Homo Sapiens Sequences Data: 5E23_A , 5E23_B
5E4A
Human transthyretin (ttr) complexed with (2,7-dichloro-fluoren-9-ylideneaminooxy)-acetic acid. Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Stura, E.A.
Date: 2015-10-05 Method: X-RAY DIFFRACTION Resolution: 1.33 Å Organism(s): Homo Sapiens Sequences Data: 5E4A_A , 5E4A_B
5E4O
Human transthyretin (ttr) complexed with (z)-((3,4-dichloro-phenyl)-methyleneaminooxy)-acetic acid Deposition Author(s): Ciccone, L. , Nencetti, S. , Orlandini, E. , Rossello, A. , Savko, M. , Stura, E.A.
Date: 2015-10-06 Method: X-RAY DIFFRACTION Resolution: 1.5 Å Organism(s): Homo Sapiens Sequences Data: 5E4O_A , 5E4O_B
5I0L
Crystal structure of the catalytic domain of mmp-12 in complex with a selective sugar-conjugated arylsulfonamide carboxylate water-soluble inhibitor (dc27). Deposition Author(s): Ciccone, L. , Cuffaro, D. , Rosalia, L. , Rossello, A. , Stura, E.A. , Tepshi, L.
Date: 2016-02-04 Method: X-RAY DIFFRACTION Resolution: 2.45 Å Organism(s): Homo Sapiens Sequences Data: 5I0L_A , 5I0L_B